Daily news email for March 05, 2010 | Click here for updated news
BioSpace Compugen Ltd. Appoints as President and CEO
U.S. FDA Panel Backs Bristol-Myers Squibb Company Transplant Drug
Watson Pharmaceuticals, Inc. To Sell ScinoPharm Taiwan Stake For $94 Million
Private UK Drug Firm Archimedes Pharma Raises $97 Million; Former Enzon Pharmaceuticals, Inc. Head Appointed as CEO; US Commercial Operations to be Established
Astellas Pharma Inc. Commences Tender Offer to Acquire All Outstanding Shares of OSI Pharmaceuticals, Inc. for $52 per Share in Cash; Bid Goes Hostile
|
BioSpace - Breaking News Merck & Co., Inc. Unit Held Liable in Australian Vioxx Case
VGXI, Inc. Expands Manufacturing Facility, Adds Key Personnel
US FDA Staff Say Effect of InterMune, Inc. Lung Drug Unclear
Pfizer Inc. , Bristol-Myers Squibb Company Anti-Clot Drug Promising in New Trial
Dow AgroSciences LLC Announces More Than $340 Million, Multi-Year Research and Development Expansion in Indianapolis; More Than 550 Jobs to Be Added
|
Biotech News - Business Wire Stentys self-expanding stent receives CE Marking to treat acute coronary syndrome (ACS)
Life Technologies, TGen and US Oncology Partner on Groundbreaking Breast Cancer Sequencing Research
Thermo Fisher Scientific Completes Acquisition of Finnzymes
SEED Competition for China Life Science Announces Finalists
Removal of Tax Barriers Opens Door to Flow of Foreign Capital for Biotech
|